Business Wire
16 Aug 2026, 13:51 UTC · 1w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
2 claims · each scored for market impact
A federal securities class action lawsuit has been filed against Aardvark Therapeutics (NASDAQ: AARD). — Class action lawsuits typically create downward pressure on stock prices due to potential legal liabilities and perceived corporate governance failures.
-0.60Law firm Faruqi & Faruqi, LLP is investigating potential additional claims against Aardvark Therapeutics. — Ongoing investigations by securities law firms suggest a potential for further litigation or the expansion of existing claims.
-0.30Which stocks this story touches
The company is facing a federal securities class action lawsuit and an investigation by a securities law firm.
Continue reading
6 related stories
Top 2 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
50m ago
